3D spatially-resolved geometrical and functional models of human liver tissue reveal new aspects of NAFLD progression
F. Segovia-Miranda, H. Morales-Navarrete, M. Kucken, V. Moser, S. Seifert, U. Repnik, F. Rost, A. Hendriks, S. Hinz, C. Rocken, D. Luthjohann, Y. Kalaidzidis, C. Schafmayer, L. Brusch, J. Hampe, M. Zerial
Abstract
Early disease diagnosis is key for the effective treatment of diseases. It relies on the identification of biomarkers and morphological inspection of organs and tissues. Histopathological analysis of human biopsies is the gold standard to diagnose tissue alterations. However, this approach has low resolution and overlooks 3D structural changes that are consequence of functional alterations. Here, we applied multiphoton imaging, 3D digital reconstructions and computational simulations to generate spatially-resolved geometrical and functional models of human liver tissue at different stages of non-alcoholic fatty liver disease (NAFLD). We identified a set of new morphometric cellular parameters correlated with disease progression. Moreover, we found profound topological defects in the 3D bile canaliculi (BC) network. Personalized biliary fluid dynamic simulations predicted an increased pericentral biliary pressure and zonated cholestasis, consistent with elevated cholestatic biomarkers in patients sera. Our spatially-resolved models of human liver tissue can contribute to high-definition medicine by identifying quantitative multi-parametric cellular and tissue signatures to define disease progression and provide new insights into NAFLD pathophysiology.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Computational hypothesis: How Intra-hepatic functional heterogeneity may influence the cascading progression of free fatty acid-induced non-alcoholic fatty liver disease (NAFLD)
Hermann−Georg Holzhütter, Nikolaus Berndt·CellsPeer-reviewed·Mar 5, 2021
- Novel 3D Approach to Model Non-Alcoholic Fatty Liver Disease using human Pluripotent Stem Cells
Carola Maria Morell, Samantha Grace Tilson, … Ludovic Vallier·bioRxiv·Feb 7, 2024
- Collagen co-localised with macrovesicular steatosis for fibrosis progression in non-alcoholic fatty liver disease
X.-X. Wang, R. Jin, … F. Liu·bioRxiv·Feb 10, 2023
- Longitudinal analysis of a dietary mouse model of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
M. M. Saenz, J. C. McDonough, … L. S. Trevino·bioRxiv·May 19, 2023
- Raman imaging analysis of microvesicular and macrovesicular lipid droplets in non-alcoholic fatty liver disease
T. Minamikawa, M. Ichimura-Shimizu, … K. Tsuneyama·bioRxiv·Jul 20, 2020
- Detecting altered hepatic lipid oxidation by MRI in an animal model of NAFLD
M. A. McLeod, M. Ragavan, … M. Merritt·bioRxiv·Aug 16, 2023